Table 4. MULTIVARIATE MODEL OF RISK FACTORS FOR CV MORTALITY IN FEMALES.
RISK PHENO-/GENOTYPE | MODEL 1 CLINICAL VARIABELES | P | MODEL 2 CLINICAL AND GENETIC VARIABLES | P |
APOE (E3E4/E4E4 and –219 TT) | 2.9 [1.9–4.4] | 2.6e−6 * | ||
T2D | 1.7 [1.0–2.9] | 3.9e−2 | ||
Fasting plasma glucose | 1.1 [1.1–1.2] | 1.3e−5 | 1.2 [1.1–1.2] | 2.3e−10 |
BMI | 1.0 [1.0–1.1] | 2.2e−2 | ||
Hypertension | 1.6 [1.1–2.4] | 2.9e−2 | 1.9 [1.2–3.1] | 7.3e−3 |
Earlier CV events | 1.6 [1.1–2.3] | 1.2e−2 | 1.9 [1.3–2.8] | 5.9e−4 |
Low physical activity | 2.1 [1.4–3.1] | 2.5e−4 | 1.9 [1.2–2.8] | 4.9e−3 |
P-value (model, Wald test) | 5.4e−14 | <1.0e−10 |
Multivariate Cox regression analysis using stepwise forward inclusion with robust variance estimates. Adjusted for age, sex and family correlations. * Pc = 7.8e−6